BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31107888)

  • 1. The evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skin.
    Rice FL; Houk G; Wymer JP; Gosline SJC; Guinney J; Wu J; Ratner N; Jankowski MP; La Rosa S; Dockum M; Storey JR; Carroll SL; Albrecht PJ; Riccardi VM
    PLoS One; 2019; 14(5):e0216527. PubMed ID: 31107888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatiotemporal Loss of
    Chen Z; Mo J; Brosseau JP; Shipman T; Wang Y; Liao CP; Cooper JM; Allaway RJ; Gosline SJC; Guinney J; Carroll TJ; Le LQ
    Cancer Discov; 2019 Jan; 9(1):114-129. PubMed ID: 30348677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head circumference and anthropometric changes and their relation to plexiform and skin neurofibromas in sporadic and familial neurofibromatosis 1 Brazilian adults: a cross-sectional study.
    Basto DL; de Souza Vieira G; Andrade-Losso RM; Almeida PN; Riccardi VM; Rozza-de-Menezes RE; Cunha KS
    Orphanet J Rare Dis; 2022 Sep; 17(1):341. PubMed ID: 36064430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous neurofibromas in the genomics era: current understanding and open questions.
    Allaway RJ; Gosline SJC; La Rosa S; Knight P; Bakker A; Guinney J; Le LQ
    Br J Cancer; 2018 Jun; 118(12):1539-1548. PubMed ID: 29695767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1.
    Well L; Jaeger A; Kehrer-Sawatzki H; Farschtschi S; Avanesov M; Sauer M; de Sousa MT; Bannas P; Derlin T; Adam G; Mautner VF; Salamon JM
    PLoS One; 2020; 15(4):e0232031. PubMed ID: 32343738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular Origin, Tumor Progression, and Pathogenic Mechanisms of Cutaneous Neurofibromas Revealed by Mice with
    Radomska KJ; Coulpier F; Gresset A; Schmitt A; Debbiche A; Lemoine S; Wolkenstein P; Vallat JM; Charnay P; Topilko P
    Cancer Discov; 2019 Jan; 9(1):130-147. PubMed ID: 30348676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiation.
    Yu Y; Choi K; Wu J; Andreassen PR; Dexheimer PJ; Keddache M; Brems H; Spinner RJ; Cancelas JA; Martin LJ; Wallace MR; Legius E; Vogel KS; Ratner N
    Acta Neuropathol; 2020 Jan; 139(1):157-174. PubMed ID: 31664505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous neurofibromas: Current clinical and pathologic issues.
    Ortonne N; Wolkenstein P; Blakeley JO; Korf B; Plotkin SR; Riccardi VM; Miller DC; Huson S; Peltonen J; Rosenberg A; Carroll SL; Verma SK; Mautner V; Upadhyaya M; Stemmer-Rachamimov A
    Neurology; 2018 Jul; 91(2 Suppl 1):S5-S13. PubMed ID: 29987130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plexiform neurofibromas express the transcription factor Gli1.
    Endo H; Oikawa A; Utani A; Shinkai H
    Dermatology; 2004; 209(4):284-7. PubMed ID: 15539889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells.
    Ferrer M; Gosline SJC; Stathis M; Zhang X; Guo X; Guha R; Ryman DA; Wallace MR; Kasch-Semenza L; Hao H; Ingersoll R; Mohr D; Thomas C; Verma S; Guinney J; Blakeley JO
    Sci Data; 2018 Jun; 5():180106. PubMed ID: 29893754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.
    Carrió M; Mazuelas H; Richaud-Patin Y; Gel B; Terribas E; Rosas I; Jimenez-Delgado S; Biayna J; Vendredy L; Blanco I; Castellanos E; Lázaro C; Raya Á; Serra E
    Stem Cell Reports; 2019 Feb; 12(2):411-426. PubMed ID: 30713041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased nuclear translation of YAP might act as a potential therapeutic target for NF1-related plexiform neurofibroma.
    Liu JL; You YH; Tian ZW; Xiao M; Zheng JW; Wang YA; Du Z
    Int J Med Sci; 2021; 18(9):2008-2016. PubMed ID: 33850471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan in intra-operative edema of NF1-associated neurofibromas.
    Hagel C; Behrens T; Prehm P; Schnabel C; Glatzel M; Friedrich RE
    Neuropathology; 2012 Aug; 32(4):406-14. PubMed ID: 22129111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling iPSC-derived human neurofibroma-like tumors in mice uncovers the heterogeneity of Schwann cells within plexiform neurofibromas.
    Mazuelas H; Magallón-Lorenz M; Fernández-Rodríguez J; Uriarte-Arrazola I; Richaud-Patin Y; Terribas E; Villanueva A; Castellanos E; Blanco I; Raya Á; Chojnacki J; Heyn H; Romagosa C; Lázaro C; Gel B; Carrió M; Serra E
    Cell Rep; 2022 Feb; 38(7):110385. PubMed ID: 35172160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of nerve microenvironment for neurofibroma development.
    Liao CP; Pradhan S; Chen Z; Patel AJ; Booker RC; Le LQ
    Oncotarget; 2016 Sep; 7(38):61500-61508. PubMed ID: 27517146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Schwann cell dedifferentiation originate dermal neurofibromas?
    Iribar H; Jaka A; Ormaechea N; Tuneu A; Izeta A; Gutiérrez-Rivera A
    Exp Dermatol; 2016 Nov; 25(11):901-903. PubMed ID: 27303947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heightened CXCR4 and CXCL12 expression in NF1-associated neurofibromas.
    Karaosmanoglu B; Kocaefe ÇY; Söylemezoğlu F; Anlar B; Varan A; Vargel İ; Ayter S
    Childs Nerv Syst; 2018 May; 34(5):877-882. PubMed ID: 29455242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment.
    Kershner LJ; Choi K; Wu J; Zhang X; Perrino M; Salomonis N; Shern JF; Ratner N
    JCI Insight; 2022 Sep; 7(18):. PubMed ID: 36134665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral Nerve Sheath Tumors in Patients With Neurofibromatosis Type 1: Morphological and Immunohistochemical Study.
    Friedrich RE; Nörnberg LKN; Hagel C
    Anticancer Res; 2022 Mar; 42(3):1247-1261. PubMed ID: 35220215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
    Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
    Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.